Linifanib (ABT-869) (GMP) is Linifanib (HY-50751) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRbeta, and FLT3, respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells[1].
Molecular Weight:
375.40
Purity:
99.9
CAS Number:
[796967-16-3]
Formula:
C21H18FN5O
Target:
PDGFR,VEGFR
Application Notes:
MCE Product type: GMP Small Molecules
* VAT and and shipping costs not included. Errors and price changes excepted
